176 related articles for article (PubMed ID: 38308693)
21. Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
Cykowski MD; Arumanayagam AS; Powell SZ; Rivera AL; Abner EL; Roman GC; Masdeu JC; Nelson PT
Acta Neuropathol; 2022 May; 143(5):531-545. PubMed ID: 35366087
[TBL] [Abstract][Full Text] [Related]
22. Performance of a condensed protocol to assess limbic-predominant age-related TDP-43 encephalopathy neuropathologic change.
Maioli H; Mittenzwei R; Shofer JB; Scherpelz KP; Marshall D; Nolan AL; Nelson PT; Keene CD; Latimer CS
J Neuropathol Exp Neurol; 2023 Jun; 82(7):611-619. PubMed ID: 37195467
[TBL] [Abstract][Full Text] [Related]
23. Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old.
Wang SJ; Guo Y; Ervin JF; Lusk JB; Luo S
Acta Neuropathol; 2022 Jul; 144(1):45-57. PubMed ID: 35551470
[TBL] [Abstract][Full Text] [Related]
24. Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations.
Besser LM; Teylan MA; Nelson PT
J Neuropathol Exp Neurol; 2020 Mar; 79(3):305-313. PubMed ID: 31845964
[TBL] [Abstract][Full Text] [Related]
25. TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains.
Estades Ayuso V; Pickles S; Todd T; Yue M; Jansen-West K; Song Y; González Bejarano J; Rawlinson B; DeTure M; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Josephs KA; Petrucelli L; Prudencio M
Mol Neurodegener; 2023 Aug; 18(1):57. PubMed ID: 37605276
[TBL] [Abstract][Full Text] [Related]
26. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.
Nelson PT; Brayne C; Flanagan ME; Abner EL; Agrawal S; Attems J; Castellani RJ; Corrada MM; Cykowski MD; Di J; Dickson DW; Dugger BN; Ervin JF; Fleming J; Graff-Radford J; Grinberg LT; Hokkanen SRK; Hunter S; Kapasi A; Kawas CH; Keage HAD; Keene CD; Kero M; Knopman DS; Kouri N; Kovacs GG; Labuzan SA; Larson EB; Latimer CS; Leite REP; Matchett BJ; Matthews FE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Nelson RS; Neltner JH; Nguyen AT; Petersen RC; Polvikoski T; Reichard RR; Rodriguez RD; Suemoto CK; Wang SJ; Wharton SB; White L; Schneider JA
Acta Neuropathol; 2022 Jul; 144(1):27-44. PubMed ID: 35697880
[TBL] [Abstract][Full Text] [Related]
27. Relation of Motor Impairments to Neuropathologic Changes of Limbic-Predominant Age-Related TDP-43 Encephalopathy in Older Adults.
Oveisgharan S; Yu L; Agrawal S; Nag S; Bennett DA; Buchman AS; Schneider JA
Neurology; 2023 Oct; 101(15):e1542-e1553. PubMed ID: 37604667
[TBL] [Abstract][Full Text] [Related]
28. Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
Di J; Nelson RS; Jicha GA; Moga DC; Barber JM; Cykowski MD; Fardo DW; Abner EL; Nelson PT
J Alzheimers Dis; 2023; 94(1):333-346. PubMed ID: 37248909
[TBL] [Abstract][Full Text] [Related]
29. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 pathology is associated with increased tau burdens and seeding.
Tomé SO; Tsaka G; Ronisz A; Ospitalieri S; Gawor K; Gomes LA; Otto M; von Arnim CAF; Van Damme P; Van Den Bosch L; Ghebremedhin E; Laureyssen C; Sleegers K; Vandenberghe R; Rousseau F; Schymkowitz J; Thal DR
Mol Neurodegener; 2023 Sep; 18(1):71. PubMed ID: 37777806
[TBL] [Abstract][Full Text] [Related]
31. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy.
Katsumata Y; Abner EL; Karanth S; Teylan MA; Mock CN; Cykowski MD; Lee EB; Boehme KL; Mukherjee S; Kauwe JSK; Kryscio RJ; Schmitt FA; Fardo DW; Nelson PT
Acta Neuropathol; 2020 Nov; 140(5):659-674. PubMed ID: 32797255
[TBL] [Abstract][Full Text] [Related]
32. A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology.
Corriveau-Lecavalier N; Botha H; Graff-Radford J; Switzer AR; Przybelski SA; Wiste HJ; Murray ME; Reichard RR; Dickson DW; Nguyen AT; Ramanan VK; McCarter SJ; Boeve BF; Machulda MM; Fields JA; Stricker NH; Nelson PT; Grothe MJ; Knopman DS; Lowe VJ; Petersen RC; Jack CR; Jones DT
medRxiv; 2023 Nov; ():. PubMed ID: 38045300
[TBL] [Abstract][Full Text] [Related]
33. Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status.
Walker JM; Richardson TE
J Neuropathol Exp Neurol; 2023 Jan; 82(2):110-119. PubMed ID: 36458951
[TBL] [Abstract][Full Text] [Related]
34. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
Katsumata Y; Shade LM; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; ; Kukull WA; Fardo DW; Nelson PT
Neurobiol Dis; 2022 Nov; 174():105880. PubMed ID: 36191742
[TBL] [Abstract][Full Text] [Related]
35. LATE Neuropathologic Changes with Little or No Alzheimer Disease is Common and is Associated with Cognitive Impairment but Not Frontotemporal Dementia.
Nelson PT
J Neuropathol Exp Neurol; 2021 Aug; 80(7):649-651. PubMed ID: 34270750
[TBL] [Abstract][Full Text] [Related]
36. Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
White LR; Corrada MM; Kawas CH; Cholerton BA; Edland SE; Flanagan ME; Montine TJ
J Alzheimers Dis; 2023; 95(1):307-316. PubMed ID: 37522210
[TBL] [Abstract][Full Text] [Related]
37. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
[TBL] [Abstract][Full Text] [Related]
38. LATE-NC staging in routine neuropathologic diagnosis: an update.
Nelson PT; Lee EB; Cykowski MD; Alafuzoff I; Arfanakis K; Attems J; Brayne C; Corrada MM; Dugger BN; Flanagan ME; Ghetti B; Grinberg LT; Grossman M; Grothe MJ; Halliday GM; Hasegawa M; Hokkanen SRK; Hunter S; Jellinger K; Kawas CH; Keene CD; Kouri N; Kovacs GG; Leverenz JB; Latimer CS; Mackenzie IR; Mao Q; McAleese KE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Neltner JH; Newell KL; Rissman RA; Saito Y; Sajjadi SA; Schwetye KE; Teich AF; Thal DR; Tomé SO; Troncoso JC; Wang SJ; White CL; Wisniewski T; Yang HS; Schneider JA; Dickson DW; Neumann M
Acta Neuropathol; 2023 Feb; 145(2):159-173. PubMed ID: 36512061
[TBL] [Abstract][Full Text] [Related]
39. Association of glial tau pathology and LATE-NC in the ageing brain.
Forrest SL; Wagner S; Kim A; Kovacs GG
Neurobiol Aging; 2022 Nov; 119():77-88. PubMed ID: 35977443
[TBL] [Abstract][Full Text] [Related]
40. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R
Tazwar M; Evia AM; Tamhane AA; Ridwan AR; Leurgans SE; Bennett DA; Schneider JA; Arfanakis K
Neurobiol Aging; 2022 Sep; 117():128-138. PubMed ID: 35728463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
